Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Neurocrine Bioscience buy Morgan Stanley

Start price
€124.65
12.06.24 / 50%
Target price
€147.54
12.06.25
Performance (%)
2.05%
Price
€127.20
26.06.24
Summary
This prediction is currently active. The BUY prediction by Morgan_Stanley shows slight gains of 2.05%. This prediction currently runs until 12.06.25. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this prediction
Performance without dividends (%)
Name 1w
Neurocrine Bioscience 3.486%
iShares Core DAX® 0.251%
iShares Nasdaq 100 -0.831%
iShares Nikkei 225® 0.590%
iShares S&P 500 -0.094%

Comments by Morgan_Stanley for this prediction

In the thread Neurocrine Bioscience diskutieren
Prediction Buy
Perf. (%) 2.05%
Target price 147.536
Change
Ends at 12.06.25

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $160.00 price target on the stock.
Ratings data for NBIX provided by MarketBeat